UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010926
Receipt number R000012785
Scientific Title Endoscopic findings detected using narrow-band imaging to distinguish between basal cell hyperplasia and squamous cell carcinoma of the pharynx
Date of disclosure of the study information 2013/06/11
Last modified on 2013/06/11 09:56:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Endoscopic findings detected using narrow-band imaging to distinguish between basal cell hyperplasia and squamous cell carcinoma of the pharynx

Acronym

NBI findings of BCH in the pharynx

Scientific Title

Endoscopic findings detected using narrow-band imaging to distinguish between basal cell hyperplasia and squamous cell carcinoma of the pharynx

Scientific Title:Acronym

NBI findings of BCH in the pharynx

Region

Japan


Condition

Condition

Basal cell hyperplasia of the pharynx and superficial-type head and neck squamous cell carcinoma

Classification by specialty

Gastroenterology Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of the present study was to clarify the endoscopic characteristics of basal cell hyperplasia that contribute to the discrimination of superficial-type head and neck squamous cell carcinoma.

Basic objectives2

Others

Basic objectives -Others

The aim of the present study was to clarify the endoscopic characteristics of basal cell hyperplasia that contribute to the discrimination of superficial-type head and neck squamous cell carcinoma.

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

The size, intervascular transparency, variety of IPCL (intra-epithelial papillary capillary loop) shapes, and the distribution of the IPCLs

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who were pathologically diagnosed as having BCH based on endoscopic biopsy samples of the pharynx obtained between January 2008 and July 2012 at our institute.

Key exclusion criteria

Cases without NBI-ME images or with only inappropriate images (blurry or unfocused) were excluded.

Target sample size

63


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuhiro Kaneko

Organization

National Cancer Center East

Division name

Department of Gastroenterology, Endoscopy Division

Zip code


Address

6-5-1, Kashiwanoha, Kashiwa, Chiba

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

National Cancer Center East

Division name

Department of Gastroenterology, Endoscopy Division

Zip code


Address


TEL


Homepage URL


Email

ayagishi@east.ncc.go.jp


Sponsor or person

Institute

National Cancer Center East

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 06 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

The size of the BCH lesions was significantly smaller (P < 0.001), and their intervascular transparency was more clearly observed (P < 0.001). IPCL (intra-epithelial papillary capillary loop) shapes were less variable and monotonous (P < 0.001), and the distribution of the IPCLs was more regular with an interval comparable to that of SCC (P < 0.001), though no significant differences in the sharpness of the lesion border or the morphological changes in the IPCLs were seen between the BCH and SCC lesions.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 01 Month 22 Day

Date of IRB


Anticipated trial start date

2013 Year 02 Month 07 Day

Last follow-up date

2013 Year 03 Month 31 Day

Date of closure to data entry

2013 Year 03 Month 31 Day

Date trial data considered complete

2013 Year 03 Month 31 Day

Date analysis concluded

2013 Year 04 Month 10 Day


Other

Other related information

case control
retrospective
consecutive cases


Management information

Registered date

2013 Year 06 Month 11 Day

Last modified on

2013 Year 06 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012785


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name